Template:Cryptosporidiosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Tarek Nafee (talk | contribs) No edit summary |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 16: | Line 16: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Cryptosporidiosis (patient information)|Patient | [[Cryptosporidiosis (patient information)|Patient Information]] | ||
|- | |- | ||
! | ! | ||
| Line 34: | Line 34: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Cryptosporidiosis | [[Cryptosporidiosis classification|Classification]] | ||
|- | |- | ||
! | ! | ||
| Line 40: | Line 40: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Cryptosporidiosis | [[Cryptosporidiosis pathophysiology|Pathophysiology]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
| Line 52: | Line 53: | ||
! | ! | ||
[[Cryptosporidiosis differential diagnosis|Differentiating Cryptosporidiosis from other Diseases]] | [[Cryptosporidiosis differential diagnosis|Differentiating Cryptosporidiosis from other Diseases]] | ||
|- | |||
! | |||
|- bgcolor="Pink" | |||
! | |||
[[Cryptosporidiosis epidemiology and demographics|Epidemiology and Demographics]] | |||
|- | |- | ||
! | ! | ||
| Line 94: | Line 101: | ||
! | ! | ||
[[Cryptosporidiosis laboratory tests|Laboratory Findings]] | [[Cryptosporidiosis laboratory tests|Laboratory Findings]] | ||
|- | |- | ||
! | ! | ||
| Line 112: | Line 113: | ||
! | ! | ||
[[Cryptosporidiosis MRI|MRI]] | [[Cryptosporidiosis MRI|MRI]] | ||
|- | |- | ||
! | ! | ||
| Line 160: | Line 149: | ||
! | ! | ||
[[Cryptosporidiosis secondary prevention|Secondary Prevention]] | [[Cryptosporidiosis secondary prevention|Secondary Prevention]] | ||
|- | |- | ||
! | ! | ||
Latest revision as of 11:57, 21 May 2017
|
Cryptosporidiosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cryptosporidiosis On the Web |
|
American Roentgen Ray Society Images of Cryptosporidiosis |